Metraipolis › archive › dc_2fdb74ddd4da

Development and validation of a CAF-related signature for prognosis and therapy response in colorectal cancer: new insights on HSPB1 — Europe PMC PMID:41407838

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41407838
DOI: 10.1038/s41698-[numero omesso]-9
License (as archived): solo-consultazione
Archived: 2026-11-07T14:20:40.774Z
SHA-256 of the archived text: d9abd82b08ffb00ad1dc3da184e15c6dece417f5efb3204390779e1493ea824c
Stable URL of this page: https://metraipolis.com/documento/dc_2fdb74ddd4da

How to cite

Development and validation of a CAF-related signature for prognosis and therapy response in colorectal cancer: new insights on HSPB1 — Europe PMC PMID:41407838 — Europe PMC (en), https://europepmc.org/article/MED/41407838 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2fdb74ddd4da (Metraipolis archive dc_2fdb74ddd4da, sha256 d9abd82b08ffb00ad1dc3da184e15c6dece417f5efb3204390779e1493ea824c)

BibTeX

@misc{dc2fdb74ddd4da,
  title = {Development and validation of a CAF-related signature for prognosis and therapy response in colorectal cancer: new insights on HSPB1 — Europe PMC PMID:41407838},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41407838},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2fdb74ddd4da; sha256 d9abd82b08ffb00ad1dc3da184e15c6dece417f5efb3204390779e1493ea824c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41407838. Agents can read the archived copy with the MCP tool read_document.